Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikkel Ostergaard

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Biomarker Insights|December 24, 2009
Changes in plasma IL-6, plasma VEGF and serum YKL-40 during Treatment with Etanercept and Methotrexate or Etanercept alone in Patients with Active Rheumatoid Arthritis Despite Methotrexate TherapyLene Surland Knudsen, Merete Lund Hetland, Julia Sidenius Johansen, et al.
Clinical Rheumatology|March 3, 2007
No erosive progression revealed by MRI in rheumatoid arthritis patients treated with etanercept, even in patients with persistent MRI and clinical signs of joint inflammationUffe Møller Døhn, Henrik Skjødt, Merete Lund Hetland, et al.
Annals of the Rheumatic Diseases|May 17, 2012
Detection, scoring and volume assessment of bone erosions by ultrasonography in rheumatoid arthritis: comparison with CTUffe Møller Døhn, Lene Terslev, Marcin Szkudlarek, et al.
RMD Open|July 20, 2019
Implementation and role of modern musculoskeletal imaging in rheumatological practice in member countries of EULARPeter Mandl, Anna Ciechomska, L Terslev, et al.
The Journal of Rheumatology|August 13, 2009
Reducing invasiveness, duration, and cost of magnetic resonance imaging in rheumatoid arthritis by omitting intravenous contrast injection -- Does it change the assessment of inflammatory and destructive joint changes by the OMERACT RAMRIS?Mikkel Ostergaard, Philip G Conaghan, Philip O'Connor, et al.
The Journal of Rheumatology|July 4, 2008
Biomarkers of inflammation in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity and radiographic outcomeLene S Knudsen, Mette Klarlund, Henrik Skjødt, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|April 8, 2025
Expert learning in musculoskeletal ultrasound - an international observational studyStine Maya Dreier Carstensen, Lawrence Grierson, Lars Konge, et al.
The Journal of Rheumatology|September 3, 2011
The OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) is reliable and sensitive to change: results from an OMERACT workshopPernille Bøyesen, Fiona M McQueen, Frédérique Gandjbakhch, et al.
Annals of the Rheumatic Diseases|October 29, 2010
No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography studyUffe Møller Døhn, Bo Ejbjerg, Annelies Boonen, et al.
Seminars in Arthritis and Rheumatism|April 25, 2015
Proceedings from the 7th Annual International Society for Musculoskeletal Imaging in Rheumatology (ISEMIR) conferenceOrrin M Troum, Olga L Pimienta, Wolfgang A Schmidt, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Biomarker Insights|December 24, 2009
Changes in plasma IL-6, plasma VEGF and serum YKL-40 during Treatment with Etanercept and Methotrexate or Etanercept alone in Patients with Active Rheumatoid Arthritis Despite Methotrexate TherapyLene Surland Knudsen, Merete Lund Hetland, Julia Sidenius Johansen, et al.
Clinical Rheumatology|March 3, 2007
No erosive progression revealed by MRI in rheumatoid arthritis patients treated with etanercept, even in patients with persistent MRI and clinical signs of joint inflammationUffe Møller Døhn, Henrik Skjødt, Merete Lund Hetland, et al.
Annals of the Rheumatic Diseases|May 17, 2012
Detection, scoring and volume assessment of bone erosions by ultrasonography in rheumatoid arthritis: comparison with CTUffe Møller Døhn, Lene Terslev, Marcin Szkudlarek, et al.
RMD Open|July 20, 2019
Implementation and role of modern musculoskeletal imaging in rheumatological practice in member countries of EULARPeter Mandl, Anna Ciechomska, L Terslev, et al.
The Journal of Rheumatology|August 13, 2009
Reducing invasiveness, duration, and cost of magnetic resonance imaging in rheumatoid arthritis by omitting intravenous contrast injection -- Does it change the assessment of inflammatory and destructive joint changes by the OMERACT RAMRIS?Mikkel Ostergaard, Philip G Conaghan, Philip O'Connor, et al.
The Journal of Rheumatology|July 4, 2008
Biomarkers of inflammation in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity and radiographic outcomeLene S Knudsen, Mette Klarlund, Henrik Skjødt, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|April 8, 2025
Expert learning in musculoskeletal ultrasound - an international observational studyStine Maya Dreier Carstensen, Lawrence Grierson, Lars Konge, et al.
The Journal of Rheumatology|September 3, 2011
The OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) is reliable and sensitive to change: results from an OMERACT workshopPernille Bøyesen, Fiona M McQueen, Frédérique Gandjbakhch, et al.
Annals of the Rheumatic Diseases|October 29, 2010
No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography studyUffe Møller Døhn, Bo Ejbjerg, Annelies Boonen, et al.
Seminars in Arthritis and Rheumatism|April 25, 2015
Proceedings from the 7th Annual International Society for Musculoskeletal Imaging in Rheumatology (ISEMIR) conferenceOrrin M Troum, Olga L Pimienta, Wolfgang A Schmidt, et al.
Pageof 10